| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $41.74 | $417,400.00 | -63.6% | +35.2% | +22.4% | |
| Oct 3, 2022 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 4,776 | $4.76 | $22,739.97 | -1.0% | -48.5% | -76.9% | |
| Oct 3, 2022 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 125,827 | $39.34 | $4,949,556.04 | -6.6% | +15.4% | +29.2% | |
| Oct 3, 2022 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 131 | $7.69 | $1,007.39 | -0.4% | -62.7% | -57.4% | |
| Oct 3, 2022 | BVS Bioventus Inc. | Nosenzo John84 | Fmr. Chief Commercial Officer | Sell | 142 | $8.81 | $1,251.15 | - | -62.7% | -57.4% | |
| Sep 30, 2022 | PLSE Pulse Biosciences, Inc. | Danahy Kevin Patrick85 | Chief Executive Officer | Buy | 6,500 | $2.30 | $14,950.00 | New | +19.6% | +75.2% | |
| Sep 29, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 830 | $23.02 | $19,106.60 | -0.2% | -28.4% | -41.7% | |
| Sep 29, 2022 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 12,968 | $5.61 | $72,802.35 | -7.3% | +39.1% | +49.1% | |
| Sep 29, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 6,754 | $77.35 | $522,421.90 | -10.6% | -9.8% | -79.0% | |
| Sep 29, 2022 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 463 | $23.02 | $10,658.26 | -0.4% | -28.4% | -41.7% | |
| Sep 29, 2022 | IRTC Irhythm Holdings, Inc. | Devine Douglas57 | Chief Operating Officer | Sell | 2,000 | $125.00 | $250,000.00 | -6.7% | -27.8% | -25.0% | |
| Sep 29, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 559 | $23.02 | $12,868.18 | -0.5% | -28.4% | -41.7% | |
| Sep 29, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 657 | $23.02 | $15,124.14 | -0.3% | -28.4% | -41.7% | |
| Sep 28, 2022 | NEOG Neogen Corp | Adent John Edward49 | President &CEO | Buy | 22,000 | $14.37 | $316,140.00 | +37.9% | +3.3% | +27.7% | |
| Sep 28, 2022 | NEOG Neogen Corp | Jones Douglas Edward48 | Chief Operating Officer | Buy | 7,000 | $14.31 | $100,170.00 | +253.7% | +3.3% | +27.7% | |
| Sep 28, 2022 | NXL Nexalin Technology, Inc. | Elson Marilyn | Ms. Elson Serves As CFO | Buy | 9,500 | $1.12 | $10,640.00 | +1.2% | -30.9% | -58.1% | |
| Sep 28, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 37,492 | $22.77 | $853,701.70 | -1.1% | +1.7% | -46.7% | |
| Sep 28, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 19,826 | $3.44 | $68,201.45 | -0.8% | -48.9% | -81.9% | |
| Sep 27, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 2,245 | $3.50 | $7,857.50 | -0.7% | -47.0% | -81.8% | |
| Sep 27, 2022 | STAA Staar Surgical Co | Francese James E69 | Sr. VP, Comm. Ops., Na, Apac | Sell | 35,425 | $75.00 | $2,656,875.00 | -22.7% | -34.2% | -45.3% | |
| Sep 27, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Buy | 38,078 | $0.83 | $31,604.74 | +0.2% | -13.3% | -14.3% | |
| Sep 26, 2022 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.63 | EVP, Strategy Corp Dev Inv Rel | Sell | 3,000 | $122.57 | $367,715.79 | -2.1% | -24.5% | -28.7% | |
| Sep 26, 2022 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,500 | $12.63 | $44,205.00 | -3.8% | -22.8% | -49.6% | |
| Sep 23, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 6,804 | $7.99 | $54,392.54 | +0.3% | +33.1% | 0.0% | |
| Sep 23, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 569 | $21.91 | $12,466.79 | -1.2% | -18.6% | -40.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.